These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16221230)

  • 21. Time courses of changes of para-, meta-, and ortho-tyrosine in septic patients: A pilot study.
    Szélig L; Kun S; Woth G; Molnár GA; Zrínyi Z; Kátai E; Lantos J; Wittmann I; Bogár L; Miseta A; Csontos C
    Redox Rep; 2016 Jul; 21(4):180-9. PubMed ID: 26193242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
    Muras K; Masajtis-Zagajewska A; Nowicki M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1901-8. PubMed ID: 24092829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney function and retinol status in type 2 diabetes mellitus patients.
    Gavrilov V; Harman-Boehm I; Amichay D; Tessler G; Shuster T; Friger M; Gorodischer R
    Acta Diabetol; 2012 Apr; 49(2):137-43. PubMed ID: 21688017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
    van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH
    J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin resistance, adipokines, and oxidative stress in nondiabetic, hypercholesterolemic patients: leptin as an 8-epi-prostaglandin F2alpha determinant.
    Shin MJ; Lee JH; Jang Y; Park E; Oh J; Chung JH; Chung N
    Metabolism; 2006 Jul; 55(7):918-22. PubMed ID: 16784964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary prostaglandins (PGE2 and PGI2) in hyporeninaemic hypoaldosteronism in diabetic patients with chronic renal failure.
    Gómez-Martino JR; Miralles JM; De Leon B; Hernandez MT; Tabernero JM
    Nephrol Dial Transplant; 1994; 9(3):251-6. PubMed ID: 8052430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is less accurate in patients with Type 2 diabetes when compared with healthy individuals.
    Camargo EG; Soares AA; Detanico AB; Weinert LS; Veronese FV; Gomes EC; Silveiro SP
    Diabet Med; 2011 Jan; 28(1):90-5. PubMed ID: 21166850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of urinary TGF-β1 in patients with diabetes mellitus and normal controls.
    Tsapenko MV; Nwoko RE; Borland TM; Voskoboev NV; Pflueger A; Rule AD; Lieske JC
    Clin Biochem; 2013 Oct; 46(15):1430-5. PubMed ID: 23685222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
    Kacso IM; Bondor CI; Kacso G
    Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum and urinary levels of insulin-like growth factor I in patients with chronic renal disease and diabetes mellitus: its clinical implication.
    Fujihara M; Uemasu J; Kawasaki H
    Clin Nephrol; 1996 Jun; 45(6):372-8. PubMed ID: 8793228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease.
    Sun AL; Deng JT; Guan GJ; Chen SH; Liu YT; Cheng J; Li ZW; Zhuang XH; Sun FD; Deng HP
    Diab Vasc Dis Res; 2012 Oct; 9(4):301-8. PubMed ID: 22388283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Regulation of natriuresis in diabetic nephropathy].
    Późniak J
    Ann Acad Med Stetin; 2000; 46():241-52. PubMed ID: 11712308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients].
    Caravaca F; Ruiz AB; Escola JM; Hernández Gallego R; Cerezo I; Fernández N; Barroso S; Martín MV
    Nefrologia; 2007; 27(4):466-71. PubMed ID: 17944584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary dopamine excretion in chronic renal disease.
    McClelland P; Yaqoob M; Bone JM; Thompson P; Roberts NB
    Ann Clin Biochem; 1992 Nov; 29 ( Pt 6)():646-51. PubMed ID: 1489161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL; Polkinghorne KR; Atkins RC; Chadban SJ
    Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review.
    Molnár GA; Kun S; Sélley E; Kertész M; Szélig L; Csontos C; Böddi K; Bogár L; Miseta A; Wittmann I
    Curr Med Chem; 2016; 23(7):667-85. PubMed ID: 26785996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyrosine isomers and hormonal signaling: A possible role for the hydroxyl free radical in insulin resistance.
    Molnár GA; Mikolás EZ; Szijártó IA; Kun S; Sélley E; Wittmann I
    World J Diabetes; 2015 Apr; 6(3):500-7. PubMed ID: 25897359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum concentration and renal handling of 1,5-anhydro-D-glucitol in patients with chronic renal failure.
    Shimizu H; Shouzu A; Nishikawa M; Omoto S; Hayakawa T; Miyake Y; Yonemoto T; Inada M
    Ann Clin Biochem; 1999 Nov; 36 ( Pt 6)():749-54. PubMed ID: 10586312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of serum and urinary transforming growth factor-beta levels as markers of diabetic nephropathy.
    Mogyorósi A; Kapoor A; Isono M; Kapoor S; Sharma K; Ziyadeh FN
    Nephron; 2000 Oct; 86(2):234-5. PubMed ID: 11015017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.